March 24, 2025 11:00 AM
Newmark announces the company has hired Chris Wadley, one of the nation’s leading advisors of healthcare systems and medical real estate investors, as Vice Chairman. In his new role, Wadley will advise health systems and medical companies on their real estate management, strategy, construction and leasing, leveraging his deep knowledge of the medical industry and various property types. Wadley, based in Houston, Texas, also plans to help grow Newmark’s healthcare advisory and construction management practices nationwide and reinforce Newmark’s commitment to attracting and investing in top talent.
“The growing and evolving healthcare space demands specialized real estate strategies that align with the needs of healthcare providers, real estate investors and the communities they serve,” said Elizabeth Hart, President of Leasing, North America. “Chris Wadley’s expertise in healthcare real estate positions Newmark to offer best-in-class advisory services, helping clients navigate complex leasing, development and operational challenges with precision and insight.”
Wadley joins Newmark after building one of the most successful hospital and outpatient healthcare advisory businesses in the country. Among his many other accomplishments, he oversaw one of the largest U.S. portfolio lease restructures for a hospital system in 2023 and oversaw the largest medical real estate transaction in Texas in each of 2019, 2021 and 2023.
“Chris Wadley is nationally recognized as a premier healthcare real estate advisor, having shaped some of the most significant medical real estate transactions in Texas and nationally,” said Ran Holman, Southeast Market Leader. “His relationships and proven ability to execute complex transactions will have an immediate impact for our clients and strengthen Newmark’s presence in the healthcare sector.”
Wadley most recently oversaw Healthcare and Life Sciences in the central U.S. for JLL, where he consistently ranked among the company’s top 1% of producers. His previous experience also includes time at Savill’s, Transwestern and Grubb & Ellis (acquired by Newmark).
“Newmark is creating a unique environment for top producers in medical real estate,” said Wadley. “They empower professionals to reach their full potential by investing in subject matter experts and prioritizing their needs first. This cultural advantage will flow through to the client.”
Wadley joins a growing roster of talented healthcare experts in Newmark’s ranks. Earlier this month, Justin Shepherd was named co-Head of the Healthcare Debt & Structured Finance team, where he’ll work closely with Co-Heads and Vice Chairmen Ben Appel and Jay Miele and Vice Chairman John Nero. Wadley will also work collaboratively with the industry-leading tenant representation and real estate advisory experts focused on healthcare including the former McCall & Almy, Inc., the renowned Boston-based firm Newmark acquired in 2022.
About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the twelve months ended December 31, 2024, Newmark generated revenues of over $2.7 billion. As of December 31, 2024, Newmark and our business partners together operated from approximately 170 offices with more than 8,000 professionals across four continents. To learn more, visit nmrk.com or follow @newmark.
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company’s business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.